Nadolol is a non-selective beta-blocker indicated for the management of hypertension and the long-term treatment of angina pectoris, with further clinical applications in migraine prophylaxis and the treatment… Read more


![Chemical structure of (2SR,3RS)-5-(3-{[(6RS,7SR)-6,7-Dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}-2-hydroxypropoxy)- 1,2,3,4-tetrahydronaphthalene-2,3-diol) and (1,3-Bis[(6R,7S)-6,7-dihydroxy-5,6,7,8-tetrahydronaphthalene-1-yloxy]propane-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2SR3RS-5-3-6RS7SR-67-Dihydroxy-5678-tetrahydronaphthalen-1-yloxy-2-hydroxypropoxy-1234-tetrahydronaphthalene-23-diol-and-13-Bis6R7S-67-dihydroxy-5678-.png&w=3840&q=75)
![Chemical structure of (3aS,9aR)-2,2-Dimethyl-5-(oxiran-2-ylmethoxy)-3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3aS9aR-22-Dimethyl-5-oxiran-2-ylmethoxy-3a499a-tetrahydronaphtho23-d13dioxole.png&w=3840&q=75)
![Chemical structure of (5aR,11aS)-7-((S)-2-(tert-Butylamino)propoxy)-3-hydroxy-2,4-dioxo-3,4,5a,6,11,11a-hexahydro-2H-naphtho[2,3-b][1,4]dioxepine-3-carboxylic acid hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5aR11aS-7-S-2-tert-Butylaminopropoxy-3-hydroxy-24-dioxo-345a61111a-hexahydro-2H-naphtho23-b14dioxepine-3-carboxylic-acid-hydrochloride.png&w=3840&q=75)
![Chemical structure of 1-(tert-Butylamino)-3-((2,2-dimethyl-3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxol-5-yl)oxy)propan-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F52187-21-0-1-tert-Butylamino-3-22-dimethyl-3a499a-tetrahydronaphtho23-d13dioxol-5-yloxypropan-2-ol.png&w=3840&q=75)



![Chemical structure of 2-(tert-Butyl((2S)-1-(((5aR,11aS)-3-carboxy-3-hydroxy-2,4-dioxo-3,4,5a,6,11,11a-hexahydro-2H-naphtho[2,3-b][1,4]dioxepin-7-yl)oxy)propan-2-yl)carbamoyl)-2-hydroxymalonic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-tert-Butyl2S-1-5aR11aS-3-carboxy-3-hydroxy-24-dioxo-345a61111a-hexahydro-2H-naphtho23-b14dioxepin-7-yloxypropan-2-ylcarbamoyl-2-hydroxymalonic-Acid.png&w=3840&q=75)





















![Chemical structure of rel-(3aR,9aS)-2,2-Dimethyl-3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxol-5-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F52187-19-6-rel-3aR9aS-22-Dimethyl-3a499a-tetrahydronaphtho23-d13dioxol-5-ol.png&w=3840&q=75)
![Chemical structure of rel-(3aR,9aS)-2,2-Dimethyl-3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxol-5-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2256724-57-7-rel-3aR9aS-22-Dimethyl-3a499a-tetrahydronaphtho23-d13dioxol-5-yl-acetate.png&w=3840&q=75)

Nadolol is a non-selective beta-blocker indicated for the management of hypertension and the long-term treatment of angina pectoris, with further clinical applications in migraine prophylaxis and the treatment of cirrhosis complications. Laboratories rely on this category of high-quality reference standards, which encompasses the Nadolol active pharmaceutical ingredient (API), its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for rigorous impurity profiling, method validation, and ongoing quality control protocols. By utilizing well-characterized reference standards and isotopically labelled analogs, analytical chemists can ensure the accuracy and reliability of chromatographic testing and quantification processes throughout the pharmaceutical product lifecycle.